{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:33:09Z","timestamp":1790188389438,"version":"4.1.0"},"reference-count":40,"publisher":"Informa UK Limited","issue":"9","funder":[{"name":"not","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1080\/14787210.2020.1771181","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T09:22:16Z","timestamp":1589793736000},"page":"843-847","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":54,"title":["Old and re-purposed drugs for the treatment of COVID-19"],"prefix":"10.1080","volume":"18","author":[{"given":"Shio-Shin","family":"Jean","sequence":"first","affiliation":[{"name":"Department of Emergency, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan"},{"name":"Department of Emergency Medicine, Department of Emergency and Critical Care Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan"},{"name":"Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipeis, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.02.011"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.02.001"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101623"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2020.03.019"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.37"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-020-00016-0"},{"key":"cit0008","unstructured":"Medrxiv News. [cited 2020 April 12]. Available from: https:\/\/times.hinet.net\/mobile\/news\/22831665;"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007016"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz656"},{"key":"cit0011","unstructured":"Novel coronavirus pneumonia diagnosis and treatment plan (provisional 7th edition, in Chinese). [cited 2020 Apr 12]. Available from: https:\/\/www.chinalawtranslate.com\/coronavirus-treatment-plan-7\/"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv392"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.2003.012658"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"key":"cit0015","unstructured":"Cush J NIH Consensus Guidelines for the Treatment of COVID-19, 2020 April 22. [cited 2020 May 1]. Available from: http:\/\/rheumnow.com\/content\/nih-consensus-guidelines-treatment-covid-19"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-2-69"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1432"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa237"},{"key":"cit0019","unstructured":"NEJM Journal Watch. COVID-19 update: hydroxychloroquine & recovery time\/home face masks at work\/reusing respirators. 2020 April 1 [cited 2020 Apr 5]. Available form: https:\/\/www.jwatch.org\/fw116513\/2020\/04\/01\/covid-19-update-hydroxychloroquine-recovery-time-home"},{"key":"cit0020","doi-asserted-by":"crossref","unstructured":"Chen Z, Hu J, Zhang Z, et al. Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial (preprint). MedRxIV; 2020 Mar 31 [cited 2020 Apr 11]Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2020.03.22.20040758v2.full.pdf","DOI":"10.1101\/2020.03.22.20040758"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949"},{"key":"cit0022","unstructured":"News. FDA approves COVACTA trial for RA drug Actemra in COVID-19 patients. [cited 2020 Mar 28]. Available from: https:\/\/www.pharmaceutical-business-review.com\/news\/covacta-trial-actemra-covid-19\/"},{"key":"cit0023","unstructured":"Medscape. Treatment of coronavirus disease 2019 (COVID-19): investigational drugs and other therapies: introduction, investigational antiviral agents, immunomodulators and other investigational therapies. [cited 2020 Apr 10]. Available from: https:\/\/emedicine.medscape.com\/article\/2500116-overview"},{"key":"cit0024","unstructured":"News. Incyte announces plans to initiate a phase 3 clinical trial of ruxolitinib (Jakafi\u00ae) as a treatment for patients with COVID-19 associated cytokine storm. [cited 2020 Apr 11]. Available from: https:\/\/investor.incyte.com\/news-releases\/news-release-details\/incyte-announces-plans-initiate-phase-3-clinical-trial"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.11.003"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.716100"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105944"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-007-9000-9"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182005009108"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1177\/1087057110390360"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104787"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2012.06.008"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.17-0042"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz524"},{"key":"cit0035","unstructured":"A randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in treating inflammatory lung injury and improving clinical outcomes associated with severe or critical COVID-19. (ClinicalTrials.gov NCT04326426). [cited 2020 April 10]. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04326426?term=tradipitant&cond=COVID&draw=2&rank=1"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1086\/425357"},{"key":"cit0037","unstructured":"Society of critical care medicine. COVID-19 Guidelines. [cited 2020 May 1]. Available from: https:\/\/www.sccm.org\/SurvivingSepsisCampaign\/Guidelines\/COVID-19"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.11.03"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00398-20"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.03.034"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2020.1771181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:29:32Z","timestamp":1666571372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2020.1771181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"alternative-id":["10.1080\/14787210.2020.1771181"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2020.1771181","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-04-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}